Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2019-05-06 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document text is titled "Transaktioner i forbindelse med Novozymes' aktietilbagekøbsprogram" (Transactions related to Novozymes' share buyback program) and details the number of shares bought back, the transaction value, and specific daily trade data (April 29 to May 3, 2019). This content directly relates to the company purchasing its own shares, which aligns perfectly with the definition of 'Transaction in Own Shares'. The code for this is POS.
2019-05-06 English
Trading by management and close relations of management
Director's Dealing Classification · 100% confidence The document is a formal notification of a share transaction by a person discharging managerial responsibilities (or a person closely associated with them), specifically Novo Holdings A/S, which is linked to a board member of Novozymes A/S. It explicitly cites Article 19 of the EU Market Abuse Regulation (MAR) regarding transactions by persons discharging managerial responsibilities. This falls directly under the definition of 'Director's Dealing' (DIRS).
2019-04-29 Danish
Trading by management and close relations of management
Director's Dealing Classification · 100% confidence The document title 'Transaktioner af ledende medarbejdere samt disses nærtstående' translates to 'Transactions by leading employees and their closely related parties'. This is a standard disclosure for insider trading or director dealings. The document is very short and serves as an announcement pointing to an attached PDF, which fits the criteria for a disclosure of director dealings.
2019-04-29 Danish
Director's Dealing 2019
Director's Dealing Classification · 99% confidence The document explicitly details transactions involving shares by management or close relations of management ('Trading by management and close relations of management'). It cites specific EU regulations (Article 19 of Regulation (EU) No 596/2014) which govern insider transactions and major shareholding notifications. The content focuses on the sale of shares by Novo Holdings A/S, a related party to the CEO, including transaction dates, prices, and volumes. This perfectly matches the definition of Director's Dealing (DIRS), which covers personal share transactions by directors and executives (insider trades).
2019-04-29 English
Report Publication Announcement 2019
Report Publication Announcement Classification · 95% confidence The document text is extremely short (398 characters) and explicitly directs the reader to 'Please read the full announcement in PDF' and provides an attachment link. This structure strongly indicates an announcement about the publication of a document rather than the document content itself. The title 'Trading by management and close relations of management' suggests insider trading activity. Among the provided codes, 'DIRS' (Director's Dealing) is the most specific category for insider trades. However, given the 'MENU VS MEAL' rule, since this is merely an announcement pointing to the full report, it should be classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since DIRS reports are often short announcements pointing to the full filing, and this concerns management trading, RPA is appropriate as it announces the publication of the detailed filing. If DIRS was strictly for the full filing content, RPA/RNS would be correct for the announcement wrapper. Given the context of insider trading, DIRS is the subject matter, but RPA fits the format (announcement wrapper). I will prioritize the format (announcement wrapper) over the subject matter if the subject matter is not explicitly an announcement code. Since DIRS is not an announcement code, and this is clearly an announcement wrapper, RPA is the best fit based on Rule 2.
2019-04-29 English
Agreement between Novozymes and Novo Holdings A/S on trading of shares as part of Novozymes share buyback program
Report Publication Announcement Classification · 95% confidence The document is a short announcement (512 characters) regarding a share buyback program agreement between Novozymes and Novo Holdings A/S. It directs the reader to an attached PDF for the full details. Per the 'Menu vs Meal' rule, since this is a short announcement of a document rather than the full report itself, it is classified as a Report Publication Announcement.
2019-04-29 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.